EML4-ALK fusion variant V3 is a high-risk feature conferring accelerated metastatic spread, early treatment failure and worse overall survival in ALK+ non-small cell lung cancer - Christopoulos, P; Endris, V; Bozorgmehr, F (Int J Cancer, 2018)